GC/MS System used for the determination of opioids, cocaine, and metabolites in serum, as well as for THC and metabolites in serum . The system performs automated SPE, evaporative concentration, derivatization as well as introduction to the GC/MS.
Extracted ion chromatogram resulting from a real serum sample. Quantified compounds are named.
Standard solid phase extraction cartridge (bottom) adapted for automated SPE.
Manual sample pretreatment
|All liquids (urine, blood, serum) were treated identically: 1. Protein precipitation by drop-wise addition of a mixture of 0.6 mL sample, 0.1 mL water and 20 μL internal standard solution to a mixture of 1 mL acetonitrile and 0.1 mL isopropanol. 2. Mixing and centrifugation. 3. Transfer of an aliquot (0.75 mL) of the supernatant to individual vials for both analysis methods. Tissues (brain and kidney, native and lyophilized) were homogenized. An aliquot of approximately 0.6 g was weighed and handled like the liquids above though the acetonitrile/isopropanol solution was added to the sample/standard mixture. The protein precipitation steps could be automated using a centrifuge option with the MPS, but this was not within the scope of this study.|
Automated sample preparation
|Condition SPE cartridge with 2 mL methanol and 2 mL phosphate buffer (pH 7.9)|
|Dilute the supernatant of the protein precipitation in the SPE syringe and add the diluted sample to the SPE cartridge|
|Wash the cartridge with 2 mL water, 2 mL acetic acid, and 2 mL methanol.|
|Dry cartridge briefly using a flow of nitrogen|
|Elute with 1.9 mL of dichloromethane/isopropanol/ammonia. The first 0.6 mL are discarded and the following 1.3 mL are collected in a vial|
|Evaporate the eluate to dryness at 70 °C, 8 kPa and 300 rpm in the mVAP station|
|Reconstitute in 200 μL isooctane/pyridine/MSTFA 14/5/1 (v/v/v)|
|Shake for 5 min at 90 °C for derivatization|
Inject 2 μL into the GC/MS
Calibration solutions were treated analogous to the eluates.
|Syringe:||10 μL Injection|
|Temperature:||50 °C -12 °C/s - 280 °C (5 min)|
|Pneumatics:||Splitless 3 min|
|Liner:||Quartz wool deactivated|
|Oven Temperature:||140 °C (1 min) - 120 °C/min - 225 °C (5.29 min) - 120 °C/min - 275 °C (5.2 min)|
|Post Run:||300 °C (2.5 min)|
|Column:||Rxi-5Sil MS (Restek) 30 m, di = 0.25 mm, df = 0.25 μm|
|Helium, constant flow, 1 mL/min|
|Analyte||LOD [ng/mL]||LOQ [ng/mL]||ULOC [ng/mL]|
Limit of detection (LOD), limit of quantification (LOQ) and upper limit of calibration (ULOC) for each compound using the validated, partly-automated reference method.
|Compound||Quantifier [m/z]||Qualifier [m/z]|
|Methadone-d3||226a, 303b||303a,318b, 242|
|7-Aminflunitranzepam||326b, 355a||326a,356a, 327b,354b|
Quantifier and qualifier ions for analytes and internal standards.
a Qualifier ion used in partly-automated analysis method.
b Qualifier ion used in fully automated analysis method.
Efficiently Automated Drug Analysis
Comprehensive automation of SPE-GC/MS based analysis of serum and other matrices for opioids, cocaine and metabolites.
Eberhard-Gerstel-Platz, 45473 Mülheim an der Ruhr, Germany,
and Oliver Temme, Thomas Daldrup, University Hospital Düsseldorf, Institute of Legal Medicine, Department of Forensic Toxicology, Moorenstrasse 5, 40225 Düsseldorf, Germany
Analyzing blood serum for opioids, cocaine and metabolites is a routine task in forensic laboratories. The most commonly used methods involve several manual or partly-automated sample preparation steps such as protein precipitation, solid phase extraction, evaporation and derivatization followed by GC/MS or LC/MS determination. In the work reported here, a comprehensively automated method is compared with a validated, partly-automated routine method. Following manual protein precipitation, the automated method relies on a GERSTEL MultiPurpose Sampler (MPS) to perform all remaining sample preparation steps. These include solid phase extraction (SPE), evaporation of the eluate, derivatization and introduction to the GC/MS. Quantitative analysis of close to 170 serum samples, as well as more than 50 samples of other matrices like urine, different tissues and heart blood, was performed using both methods. Cocaine, benzoylecgonine, methadone, morphine, codeine, 6-monoacetylmorphine, dihydrocodeine and 7-aminoflunitrazepam were determined quantitatively and the methods were found to produce equivalent analytical results even near the limits of quantification.
A GERSTEL MultiPurpose Sampler (MPS) was used, configured with a 2.5 mL syringe with gas supply for the sample preparation steps and a 10 μL syringe used for sample injection into a GERSTEL Cooled Injection System (CIS 4) coupled to a 7890 GC/5975 MSD (Agilent Technologies). The MPS was equipped with modules for solid phase extraction (GERSTEL SPE), for evaporation of solvents under controlled vacuum and temperature (GERSTEL mVAP), for shaking under controlled temperature conditions (Agitator) and for supplying large volumes of solvents (GERSTEL SFS).
All analytes and deuterated analogues were certified standards purchased from Lipomed AG or LGC Promochem GmbH. All solvents and salts were of analytical grade and purchased from VWR. N-Methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) for silylation was purchased from Macherey-Nagel or Sigma-Aldrich. Bond Elut Certify 130 mg, 3 mL format SPE cartridges from Agilent Technologies were used. For automated SPE these cartridges were cut at the top, equipped with a transport adapter and a disposable syringe needle (canula). Blood, urine and tissue samples were taken from authentic forensic cases at the Institute of Legal Medicine in Düsseldorf.
Preparation of standards and solutions
For calibration, multi-compound calibration solutions and one multi-compound internal standard solution containing deuterated analogues of every analyte were prepared in methanol. The calibrations ranged from 25 to 1500 ng/mL (methadone), from 50 to 1500 ng/mL (benzoylecgonine), from 5 to 150 ng/mL (codeine), from 5 to 300 ng/mL (cocaine, dihydrocodeine, morphine), and from 2.5 to 150 ng/mL (7-aminoflunitrazepam, 6-monoacetylmorphine) respectively and were calculated for 0.6 mL serum sample (nine levels). A 20 μL aliquot of the internal standard solution was added to each individual sample, calibration sample and quality control sample.
In agreement with the guidelines of the Society of Toxicological and Forensic Chemistry (GTFCh, Germany) a blank injection of pure derivatization solution was performed after every sample, quality control or calibration sample.
Results and Discussion
The validated, partly-automated routine analysis method was successfully automated using the MPS – from dilution of the sample after protein precipitation to injection into the GC/MS. Some modifications were necessary:
Dilution of the supernatant after protein precipitation was partly performed in the autosampler syringe. A 0.75 mL aliquot of the supernatant was diluted with 0.75 mL phosphate buffer and 0.75 mL of this mixture was aspirated. After that, another 1.75 mL phosphate buffer was aspirated resulting in the final dilution (same as in the reference method). This solution was added to the SPE cartridge and the process was repeated once to transfer the entire sample. The elution volume was reduced from 2 mL to 1.9 mL. The first 0.6 mL was discarded and the last 1.3 mL was collected based on an established elution profile. The derivatization time was shortened from 30 min to 5 min with shaking at 90 °C by employing a mixture of isooctane/pyridine/MSTFA 14/5/1 (v/v/v) instead of the isooctane/MSTFA 19/1 (v/v) mixture originally used.
Close to 170 serum samples and more than 50 samples of other matrices like urine, different tissues and heart blood were analyzed by both methods. Results are equivalent as can be seen in the double logarithmic line- and Bland-Altman-plots. This is true for serum samples and also for alternative matrix samples.
Relative deviations of measured concentrations displayed in Bland-Altman-plots. ng/mL: Nanogram per milliliter or nanogram per gram for tissue respectively; Other: Other matrices than serum - urine, blood, lyophilized kidney tissue, heart blood, lyophilized and native brain tissue; LOD: Limit of detection; LOQ: Limit of quantification; ULOC: Upper limit of calibration; SD: Standard deviation of relative deviations.
Correlation of determined analyte concentrations in double logarithmic scale. Line with a slope of one – representing complete equivalence of results – is shown. ng/mL: Nanogram per milliliter or nanogram per gram for tissue respectively; Other: Other matrices than serum - urine, blood, lyophilized kidney tissue, heart blood, lyophilized and native brain tissue; LOD: Limit of detection; LOQ: Limit of quantification; ULOC: Upper limit of calibration.
Although results between the limit of quantification and the limit of detection may not be reported routinely, they are included in the line plots. Even in this concentration range the method equivalence is obvious. Since only a couple of samples were positive for dihydrocodeine and 7-aminoflunitrazepam these results are not plotted. Samples and quality control samples were also in good concordance for these compounds.
No carryover for any of the compounds could be detected when extracting blank serum after real samples. By overlapping sample preparation steps with the GC/MS run a throughput of around 29 samples per day could be achieved, which is comparable with the partly automated reference method.
The analyses were performed in different laboratories by different personnel at different times proving the ruggedness of the instrumentation and methods and the suitability for routine forensic analysis tasks.
The following achievements were made:
• Comprehensive automation of a validated, partly automated analysis method for opioids, cocaine and metabolites from blood serum and other matrices.
• Analysis results of the methods were found to be equivalent based on GTFCh recommendations.
• The automated method proved to be rugged and suitable for routine analysis in forensic laboratories.
• The automated method saves manual work and reduces the risk of human error. It generates a throughput of 29 samples per day, which is similar to the reference method and is well sychronized with the GC/MS analysis time.
• The analysis system is highly flexible and can reproduce manual sample preparation workflows. Therefore it can be used to automate other validated GC or LC analysis methods or for standalone automation of sample preparation.
 O. Lerch, O. Temme, T. Daldrup: „Comprehensive automation of the solid phase extraction gaschromatographic mass spectrometric analysis (SPE-GC/MS) of opioids, cocaine, and metabolites from serum and other matrices“, Anal. Bioanal. Chem. 406 (2014) 4443; Free Download of the article
 O. Lerch, O. Temme, T. Daldrup: „Comprehensive Automation of the SPE-GC/MS Analysis of Opioids, Cocaine and Metabolites from Serum and Other Matrices“, GERSTEL AppNote 07/2013
 GERSTEL Aktuell 46 (2012) 13-15
|previous article||next article|